TAK-733

未知生产厂商

TAK-733 has been used in trials studying the treatment of Advanced Metastatic Melanoma, Advanced Nonhematologic Malignancies, and Advanced Non-hematologic Malignancies.

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

TAK-733 has been used in trials studying the treatment of Advanced Metastatic Melanoma, Advanced Nonhematologic Malignancies, and Advanced Non-hematologic Malignancies.

技术标识符

化学式: C₁₇H₁₅F₂IN₄O₄
CAS 编号: 1035555-63-5
UNII ID: 5J61HSP0QJ

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

ADMINISTRATION OF A RAF INHIBITOR AND A MEK INHIBITOR IN THE TREATMENT OF MELANOMA
US 2015126533 A1申请人: TAKEDA PHARMACEUTICAL优先权: 2013
CN
US
2 件公开
REC-4881 (TAK-733) FOR USE IN TREATING OR PREVENTING COLORECTAL CANCER AND RELATED DISEASES
WO 2025147555 A1申请人: RECURSION PHARMACEUTICALS INC优先权: 2024
CN
WO
2 件公开
Compositions and methods for treating vascular anomalies, nevus sebaceous syndrome, epidermal nevi, and neurofibromas
US 12336997 B2申请人: CHEMISTRY RX优先权: 2023
US
2 件公开

药物